Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03233854
Title CD19/CD22 Chimeric Antigen Receptor(CAR) T Cells in Adults With Recurrent/Refractory B Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Crystal Mackall, MD
Indications

primary mediastinal B-cell lymphoma

B-cell acute lymphoblastic leukemia

diffuse large B-cell lymphoma

Therapies

Cyclophosphamide + Fludarabine

CD19/CD22 CAR T cells

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.